Kết quả tìm kiếm - Jacques Delaunay

  • Đang hiển thị 1 - 19 kết quả của 19
Tinh chỉnh kết quả
  1. 1
    Impact of the hypomethylating agent 5-azacytidine on dendritic cells function

    Impact of the hypomethylating agent 5-azacytidine on dendritic cells function Bằng Jihane Frikeche, Aline Clavert, Jacques Delaunay, Éolia Brissot, Marc Grégoire, Béatrice Gaugler, Mohamad Mohty

    Được phát hành 2011
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Impact of Cyclosporine-A Concentration on the Incidence of Severe Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

    Impact of Cyclosporine-A Concentration on the Incidence of Severe Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Bằng Florent Malard, Richard Szydlo, Éolia Brissot, Patrice Chevallier, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Viviane Dubruille, Steven Le Gouill, Beatrice Mahé, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, Jean‐Luc Harousseau, Philippe Moreau, Mohamad Mohty

    Được phát hành 2009
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

    The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience Bằng Mathilde Lamarque, Sophie Raynaud, Raphaël Itzykson, Sylvain Thépot, Bruno Quesnel, François Dreyfus, Odile Beyne Rauzy, Pascal Turlure, Norbert Vey, Christian Récher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Sorin Visanica, Aspasia Stamatoullas, Pierre Fenaux, Lionel Adès

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study

    Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study Bằng Lionel Adès, Simone Boehrer, Thomas Prébet, Odile Beyne‐Rauzy, Laurence Legros, Christophe Ravoet, François Dreyfus, Aspasia Stamatoullas, Marie Pierre Chaury, Jacques Delaunay, Laurent Guy, Norbert Vey, Sara Burcheri, Rose-Marie Mbida, Natacha Hoarau, Claude Gardin, Pierre Fenaux

    Được phát hành 2008
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

    Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled tr... Bằng Robert K. Hills, Sylvie Castaigné, Frederick R. Appelbaum, Jacques Delaunay, Stephen H. Petersdorf, Megan Othus, Elihu H. Estey, Hervé Dombret, Sylvie Chevret, Norbert Ifrah, Jean‐Yves Cahn, Christian Récher, Lucy Chilton, Anthony V. Moorman, Alan K. Burnett

    Được phát hành 2014
    lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

    Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the beh... Bằng Sylvain Thépot, Raphaël Itzykson, Valérie Seegers, Emmanuel Raffoux, Bruno Quesnel, Yasmine Chaït, L. Sorin, François Dreyfus, Thomas Cluzeau, Jacques Delaunay, Laurence Sanhès, Virginie Éclache, Caroline Dartigeas, Pascal Turlure, Stéphanie Harel, Célia Salanoubat, Jean‐Jacques Kiladjian, Pierre Fenaux, Lionel Adès

    Được phát hành 2010
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment... Bằng Hagop M. Kantarjian, Xavier Thomas, Anna Dmoszyńska, Agnieszka Wierzbowska, Grzegorz Mazur, Jiří Mayer, Jyh-Pyng Gau, Wen‐Chien Chou, Rena Buckstein, Jaroslav Čermák, Ching-Yuan Kuo, Albert Oriol, Farhad Ravandi, Stefan Faderl, Jacques Delaunay, Daniel Lysák, Mark D. Minden, Christopher Arthur

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup

    Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergrou... Bằng Thomas Prébet, Nicolas Boissel, S. Reutenauer, Xavier Thomas, Jacques Delaunay, Jean‐Yves Cahn, Arnaud Pigneux, Bruno Quesnel, Francis Witz, Sylvain Thépot, Valérie Ugo, Christine Terré, Christian Récher, Emmanuelle Tavernier, Mathilde Hunault, Benjamin Esterni, Sylvie Castaigné, François Guilhot, Hervé Dombret, Norbert Vey

    Được phát hành 2009
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML Bằng Anne-Sophie Chrétien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Jean-François Hamel, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet‐Lefèbvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Didier Blaise, Daniel Olive

    Được phát hành 2017
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities

    Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities Bằng Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, Francine Mugneret, Jacques Delaunay, Jean‐Luc Harousseau, Carole Barin, Jean‐Yves Cahn, Philippe Guardiola, Chantal Himberlin, Christian Récher, Norbert Vey, Bruno Lioure, Mario Ojeda‐Uribe, Nathalie Fegueux, Christian Berthou, Edouard Randriamalala, Marie C. Béné, Norbert Ifrah, Francis Witz

    Được phát hành 2011
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire

    Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire Bằng Sophie Park, Myriam Labopin, Ibrahim Yakoub‐Agha, Jacques Delaunay, Nathalie Dhédin, Éric Deconinck, Mauricette Michallet, Marie Robin, Thierry de Revel, Marc Bernard, Norbert Vey, Bruno Lioure, Simona Lapusan, Reza Tabrizi, Jean Bourhis, Anne Huynh, Yves Béguin, Gèrard Socié, François Dreyfus, Pierre Fenaux, Mohamad Mohty

    Được phát hành 2013
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

    Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia Bằng Norbert Vey, Jacques Delaunay, Giovanni Martinelli, Walter Fiedler, Emmanuel Raffoux, Thomas Prébet, Carlos Gomez‐Roca, Cristina Papayannidis, Maxim Kebenko, Peter Paschka, R D Christen, Ernesto Guarin, Ann‐Marie Bröske, Monika Baehner, Michael Brewster, Antje‐Christine Walz, Francesca Michielin, Valeria Runza, Valérie Méresse, Christian Récher

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

    NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia Bằng Anne-Sophie Chrétien, Cyril Fauriat, Florence Orlanducci, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Samuel Granjeaud, Clémence Demerle, Jean-François Hamel, Adelheid Cerwenka, Elke Pogge von Strandmann, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet‐Lefèbvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Daniel Olive

    Được phát hành 2017
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  14. 14
    Emergence and evolution of <i>TP53</i> mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide

    Emergence and evolution of <i>TP53</i> mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide Bằng Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, Marion Eveillard, Yannick Le Bris, Catherine Godon, Olivier Theisen, Anne-Laure Gagez, Guillaume Cartron, Thérèse Commes, Bruno Villemagne, Odile Luycx, Pascal Godmer, Catherine Pellat‐Deceunynck, Thierry Soussi, Marie C. Béné, Jacques Delaunay, Pierre Péterlin

    Được phát hành 2017
    lấy văn bản
    Carta
    Lưu vào danh sách
    Đã lưu trong:
  15. 15
    Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

    Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia Bằng Anne-Sophie Chrétien, Cyril Fauriat, Florence Orlanducci, Claire Galseran, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Samuel Granjeaud, Jean‐François Hamel‐Broza, Clémence Demerle, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet‐Lefèbvre, Jacques Delaunay, Antoine Toubert, Emilie Gregori, Hervé Luche, Marie Malissen, Christine Arnoulet, Jacques A. Nunès, Norbert Vey, Daniel Olive

    Được phát hành 2017
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  16. 16
    Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

    Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine Bằng Raphaël Itzykson, Sylvain Thépot, Bruno Quesnel, François Dreyfus, Odile Beyne‐Rauzy, Pascal Turlure, Norbert Vey, Christian Récher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Célia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Françoise Isnard, Anne Marfaing‐Koka, Stéphane de Botton, Youcef Chelghoum, Anne‐Laure Taksin, Isabelle Plantier, Shanti Amé, Simone Boehrer, Claude Gardin, C.L. Beach, Lionel Adès, Pierre Fenaux

    Được phát hành 2010
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  17. 17
    Azacitidine in untreated acute myeloid leukemia: A report on 149 patients

    Azacitidine in untreated acute myeloid leukemia: A report on 149 patients Bằng Sylvain Thépot, Raphaël Itzykson, Valérie Seegers, Christian Récher, Emmanuel Raffoux, Bruno Quesnel, Jacques Delaunay, Thomas Cluzeau, Anne Marfaing Koka, Aspasia Stamatoullas, Marie‐Pierre Chaury, Caroline Dartigeas, Stéphane Chèze, Anne Banos, Pierre Morel, Isabelle Plantier, Anne‐Laure Taksin, Jean Pierre Marolleau, Cécile Pautas, Xavier Thomas, Françoise Isnard, Blandine Bève, Yasmine Chaït, Agnès Guerci, Norbert Vey, François Dreyfus, Lionel Adès, Norbert Ifrah, Hervé Dombret, Pierre Fenaux, Claude Gardin

    Được phát hành 2013
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  18. 18
    Clinical and biological features in <i>PIEZO1</i>-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients

    Clinical and biological features in <i>PIEZO1</i>-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients Bằng Véronique Picard, Corinne Guitton, Isabelle Thuret, Christian Rosé, Laurence Bendélac, Khaldoun Ghazal, Patricia Aguilar‐Martinez, Catherine Badens, Claire Barro, Claire Bénéteau, Claire Berger, P. Cathébras, Éric Deconinck, Jacques Delaunay, J.M. Durand, Nadia Firah, Frédéric Galactéros, Bertrand Godeau, Xavier Jaïs, Jean-Pierre de Jaureguiberry, Camille Le Stradic, François Lifermann, Robert Maffre, G Morin, Julien Perrin, Valérie Proulle, M. Ruivard, Fabienne Toutain, Agnès Lahary, Loïc Garçon

    Được phát hành 2019
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  19. 19
    Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

    Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial Bằng Xavier Leleu, Cyrille Hulin, Jérôme Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin, Murielle Roussel, Lydia Montes, Brieuc Chérel, Thomas Chalopin, Borhane Slama, Marie‐Lorraine Chrétien, Kamel Laribi, C. Dingremont, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Alberto Santagostino, Margaret Macro, Emmanuelle Bourgeois, Frédérique Orsini‐Piocelle, Julie Gay, Benoît Bareau, Noémie Bigot, François Vergez, Pierre Lebreton, Reza Tabrizi, Agathe Waultier‐Rascalou, Laurent Frenzel, Ronan Le Calloch, Émilie Chalayer, Thorsten Braun, Florence Lachenal, Sélim Corm, Celine Kennel, Rakiba Belkhir, Jean‐Sébastien Blade, Bertrand Joly, Valentine Richez-Olivier, Hélène Gardeney, Hélène Demarquette, Daniela Robu-Cretu, Laurent Garderet, Muriel Newinger-Porte, Amine Kasmi, Bruno Royer, Pascale Olivier, Bertrand Arnulf, Karim Belhadj, Cyrille Touzeau, Mohamad Mohty, Salomon Manier, Philippe Moreau, Hervé Avet‐Loiseau, Jill Corre, Thierry Façon

    Được phát hành 2024
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: